Literature DB >> 26298516

CAV-2--why a canine virus is a neurobiologist's best friend.

Felix Junyent1, Eric J Kremer2.   

Abstract

Canine adenovirus type 2 (CAV-2) vectors are powerful tools for fundamental and applied neurobiology due to their negligible immunogenicity, preferential transduction of neurons, widespread distribution via axonal transport, and duration of expression in the mammalian brain. CAV-2 vectors are internalized in neurons by the selective use of coxsackievirus and adenovirus receptor (CAR), which is located at the presynapse in neurons. Neuronal internalization and axonal transport is mediated by CAR, which potentiates vector biodistribution. The above characteristics, together with the ∼30kb cloning capacity of helper-dependent (HD) CAV-2 vectors, optimized CAV-2 vector creation, production and purification, is expanding the therapeutic and fundamental options for CNS gene transfer.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26298516     DOI: 10.1016/j.coph.2015.08.004

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  46 in total

1.  Integrated Control of Predatory Hunting by the Central Nucleus of the Amygdala.

Authors:  Wenfei Han; Luis A Tellez; Miguel J Rangel; Simone C Motta; Xiaobing Zhang; Isaac O Perez; Newton S Canteras; Sara J Shammah-Lagnado; Anthony N van den Pol; Ivan E de Araujo
Journal:  Cell       Date:  2017-01-12       Impact factor: 41.582

Review 2.  Emerging role of viral vectors for circuit-specific gene interrogation and manipulation in rodent brain.

Authors:  Erika Sarno; Alfred J Robison
Journal:  Pharmacol Biochem Behav       Date:  2018-04-27       Impact factor: 3.533

3.  What is CAR doing in the middle of the adult neurogenic road?

Authors:  Sara Salinas; Felix Junyent; Nathalie Coré; Harold Cremer; Eric J Kremer
Journal:  Neurogenesis (Austin)       Date:  2017-04-27

Review 4.  Strategies for targeting primate neural circuits with viral vectors.

Authors:  Yasmine El-Shamayleh; Amy M Ni; Gregory D Horwitz
Journal:  J Neurophysiol       Date:  2016-04-06       Impact factor: 2.714

Review 5.  Optogenetic approaches for dissecting neuromodulation and GPCR signaling in neural circuits.

Authors:  Skylar M Spangler; Michael R Bruchas
Journal:  Curr Opin Pharmacol       Date:  2016-11-19       Impact factor: 5.547

6.  DCC Receptors Drive Prefrontal Cortex Maturation by Determining Dopamine Axon Targeting in Adolescence.

Authors:  Lauren M Reynolds; Matthew Pokinko; Angélica Torres-Berrío; Santiago Cuesta; Laura C Lambert; Esther Del Cid Pellitero; Michael Wodzinski; Colleen Manitt; Paul Krimpenfort; Bryan Kolb; Cecilia Flores
Journal:  Biol Psychiatry       Date:  2017-06-16       Impact factor: 13.382

Review 7.  Neural systems mediating the inhibition of cocaine-seeking behaviors.

Authors:  Victória A Muller Ewald; Ryan T LaLumiere
Journal:  Pharmacol Biochem Behav       Date:  2017-07-15       Impact factor: 3.533

8.  Coxsackievirus Adenovirus Receptor Loss Impairs Adult Neurogenesis, Synapse Content, and Hippocampus Plasticity.

Authors:  Charleine Zussy; Fabien Loustalot; Felix Junyent; Fabrizio Gardoni; Cyril Bories; Jorge Valero; Michel G Desarménien; Florence Bernex; Daniel Henaff; Neus Bayo-Puxan; Jin-Wen Chen; Nicolas Lonjon; Yves de Koninck; João O Malva; Jeffrey M Bergelson; Monica di Luca; Giampietro Schiavo; Sara Salinas; Eric J Kremer
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

Review 9.  Dopaminergic dysfunction in neurodevelopmental disorders: recent advances and synergistic technologies to aid basic research.

Authors:  J Elliott Robinson; Viviana Gradinaru
Journal:  Curr Opin Neurobiol       Date:  2017-08-30       Impact factor: 6.627

Review 10.  Nonhuman Primate Optogenetics: Recent Advances and Future Directions.

Authors:  Adriana Galvan; William R Stauffer; Leah Acker; Yasmine El-Shamayleh; Ken-Ichi Inoue; Shay Ohayon; Michael C Schmid
Journal:  J Neurosci       Date:  2017-11-08       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.